Skip to main content

Hoge Stephen's Form 4 filing

Moderna, Inc. (MRNA) · filed Feb 25, 2026

Accession no.
0001682852-26-000036
Filed
Feb 25, 2026
Trade date
Feb 23, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.81M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoge StephenCIK 0001760669Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 23, 2026Common StockMOption exerciseAcquired+111,679$19.15+$2,138,652.851,569,106Direct
Feb 23, 2026Common StockMOption exerciseAcquired+48,330$19.15+$925,519.51,617,436Direct
Feb 23, 2026Common StockSSaleDisposed−160,009$48.84−$7,814,839.561,457,427Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 23, 2026Common StockMOption exerciseDisposed−111,679$0.00$0111,678Direct
Feb 23, 2026Common StockMOption exerciseDisposed−48,330$0.00$048,330Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)